The current Ebola crisis in West Africa is on pace to sicken more people than all other previous outbreaks of the disease combined, a U.S. health official said Thursday. Dr. Tom Frieden, director of the Centers for Disease Control and Prevention, told a congressional hearing that the outbreak is unprecedented in part because it's in a region of Africa that never has dealt with Ebola before.
A bug can turn you into a vegetarian, or at least make you swear off red meat. Doctors across the nation are seeing a surge of sudden meat allergies in people bitten by a certain kind of tick. This bizarre problem was only discovered a few years ago but is growing as the ticks spread from the Southwest and the East to more parts of the United States.
Researchers at Yale School of Medicine have discovered a new drug compound that reverses the brain deficits of Alzheimer’s disease in an animal model. The compound, TC-2153, inhibits the negative effects of a protein called STtriatal-Enriched tyrosine Phosphatase (STEP), which is key to regulating learning and memory. These cognitive functions are impaired in Alzheimer’s.
Sequencing the genomes of tumor cells has revealed thousands of mutations associated with cancer. One way to discover the role of these mutations is to breed a strain of mice that carry the genetic flaw—but breeding such mice is an expensive, time-consuming process. Now, Massachusetts Institute of Technology researchers have found an alternative.
It's long been known that faulty BRCA genes greatly raise the risk for breast cancer. Now scientists say a more recently identified, less common gene can do the same. Mutations in the gene can make breast cancer up to nine times more likely to develop, an international team of researchers reports in the New England Journal of Medicine.
The use of an experimental drug to treat two Americans diagnosed with Ebola is raising ethical questions about who gets first access to unproven new therapies for the deadly disease. But some health experts fear debate over extremely limited doses will distract from tried-and-true measures to curb the growing outbreak.
Cytori Therapeutics said Tuesday it has halted trials of its experimental stem cell therapy for heart failure after three patients developed blood flow problems. The San Diego-based company said it placed the hold on two studies after the patients developed problems with blood flow to the brain. Two of the patients' symptoms resolved in a short period of time and a third was still recovering, the company said in a statement.
A new technique for studying the lifecycle of the hepatitis B virus could help researchers develop a cure for the disease. A recently published paper describes using microfabricated cell cultures to sustain hepatitis B virus in human liver cells, allowing them to study immune responses and drug treatments.
A man who recently visited West Africa was placed in isolation at a city hospital and was undergoing tests for possible Ebola, officials said Monday. The man, suffering from a high fever and gastrointestinal symptoms, arrived at Mount Sinai Medical Center in Manhattan early on Monday, the hospital said. He had recently traveled to a West African country where Ebola has been reported, it said.
A flu virus acts like a Trojan horse as it attacks and infects host cells. Scientists at Rice Univ. and Baylor College of Medicine have acquired a clearer view of the well-hidden mechanism involved. Their computer simulations may lead to new strategies to stop influenza, perhaps even a one-size-fits-all vaccine.
When two U.S. aid workers infected with Ebola arrive in Atlanta from Africa, they will be whisked into one of the most sophisticated hospital isolation units in the country. The specialized unit at Emory Univ. Hospital was opened a dozen years ago to care for federal health workers exposed to some of the world's most dangerous germs.
Researchers at Yale School of Medicine have pinpointed a mechanism in part of the brain that is key to sensing glucose levels in the blood, linking it to both type 1 and type 2 diabetes. The findings are published in the Proceedings of the National Academies of Sciences.
Imagine you're fighting for your life but no matter how hard you hit, your opponent won't go down. The same can be said of highly treatment-resistant cancers, such as head and neck cancer, where during radiation and chemotherapy some cancer cells repair themselves, survive and thrive. Head and neck cancer is the sixth most common cancer in the world, but the late detection and treatment resistance result in a high mortality rate.
Soon, protection from HIV infection could be as simple as inserting a medicated, disappearing fabric minutes before having sex. Univ. of Washington bioengineers have discovered a potentially faster way to deliver a topical drug that protects women from contracting HIV. Their method spins the drug into silk-like fibers that quickly dissolve when in contact with moisture, releasing high doses of the drug.
Some people can handle stressful situations better than others, and it’s not all in their genes: Even identical twins show differences in how they respond. Researchers have identified a specific electrical pattern in the brains of genetically identical mice that predicts how well individual animals will fare in stressful situations. The findings may eventually help researchers prevent potential consequences of chronic stress.
A new stem cell discovery might one day lead to a more streamlined process for obtaining stem cells, which in turn could be used in the development of replacement tissue for failing body parts, according to Univ. of California, San Francisco scientists who reported the findings in Cell.
Fifteen years ago, Massachusetts Institute of Technology professor John Essigmann and colleagues from the Univ. of Washington had a novel idea for an HIV drug. They thought if they could induce the virus to mutate uncontrollably, they could force it to weaken and eventually die out—a strategy that our immune system uses against many viruses.
A $1,000-per-pill drug that insurers are reluctant to pay for has quickly become the treatment of choice for a liver-wasting viral disease that affects more than three million Americans. In less than six months, prescriptions for Sovaldi have eclipsed all other hepatitis C pills combined, according to new data from IMS Health.
There is no cure for Alzheimer’s disease and other forms of dementia, but the research community is one step closer to finding treatment. Univ. of Washington bioengineers have a designed a peptide structure that can stop the harmful changes of the body’s normal proteins into a state that’s linked to widespread diseases such as Alzheimer’s, Parkinson’s, heart disease, Type 2 diabetes and Lou Gehrig’s disease.
The Wyss Institute for Biologically Inspired Engineering at Harvard Univ. announced that its human “Organs-on-Chips” technology will be commercialized by a newly formed private company to accelerate development of pharmaceutical, chemical, cosmetic and personalized medicine products.
A costly drug given mostly to premature babies is at the center of a clash between the manufacturer and the nation's leading pediatrician's group, which recommends scaling back use of the medicine. The dispute involves new guidelines from the American Academy of Pediatrics, which say medical evidence shows the drug benefits few children other than very young preemies.
Virologists and biologists in California have identified a highly abundant, never-before-described virus that could play a major role in obesity, diabetes. The virus, named crAssphage, has about 10 times as many base pairs of DNA as HIV and infects one of the most common types of gut bacteria. This phylum of bacteria is thought to be connected with obesity, diabetes and other gut-related diseases.
The drought that has the entire country in its grip is affecting more than the color of people’s lawns. It may also be responsible for the proliferation of a heat-loving amoeba commonly found in warm freshwater bodies, such as lakes, rivers and hot springs, which the drought has made warmer than usual this year.
Fragile X syndrome (FXS) is a genetic disorder that causes obsessive compulsive and repetitive behaviors, and other behaviors on the autistic spectrum, as well as cognitive deficits. It’s the most common inherited cause of mental impairment and the most common cause of autism. Now biomedical scientists at the Univ. of California, Riverside have published a study that sheds light on the cause of autistic behaviors in FXS.
The U.S. Food and Drug Administration on Wednesday approved a new cancer drug from Gilead Sciences Inc. to treat three types of blood cancer. Regulators approved the drug for patients with forms of chronic lymphocytic leukemia, follicular lymphoma and small lymphocytic lymphoma. The cancers affect an estimated 200,000 patients in the U.S., according to Gilead.